1-9 of 9
Zhu Li
Close
Sort by
Journal Articles

Mitigating the Risk of Cytokine Release Syndrome (CRS): Preliminary Results from a DLBCL Cohort of Epcore NHL-1

Julie M. Vose, Tatyana Feldman, Martine E.D. Chamuleau, Won Seog Kim, Pieternella Lugtenburg, Tae Min Kim, Pau Abrisqueta Costa, Chan Y. Cheah, Ingrid Cecilia Glimelius, Brian Hess, Wojciech Jurczak, Gerardo Musuraca, Adam J. Olszewski, Minh Dinh, Nurgul Kilavuz, Monica Wielgos-Bonvallet, Tommy Li, Zhu Li, Christian Eskelund, Umar Farooq
Journal: Blood
Blood (2023) 142 (Supplement 1): 1729.
https://doi.org/10.1182/blood-2023-180333
Published: 2023
Journal Articles

Developing “Off-the-Shelf” CLL1 CAR-DNT Therapeutics for the R/R Acute Myeloid Leukemia

Xu Beilei, Chao Zhang, Junxiao Gao, Zhu Li, Shengzhen Ding, Li Liu, Hang Zhang, Lulu Lyu, Li Zhou
Journal: Blood
Blood (2023) 142 (Supplement 1): 3442.
https://doi.org/10.1182/blood-2023-173608
Published: 2023
Journal Articles

Home Treatment of Bortezomib: A Preliminary Exploration of a New Treatment Mode in China

Congli Zhang, Xin-xin Cao, Dong-zhu Li, Jun Feng, MD, Lu Zhang, MD, Yan Zhang, Ming-hui Duan, MD, Miao Chen, MD, Chen Yang, Wei Wang, Dao-Bin Zhou, Jian Li, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2127.
https://doi.org/10.1182/blood-2019-125505
Published: 2019
Journal Articles

Randomized, Double-Blind Trial of Ferumoxytol Compared to Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia: Safety and Efficacy

Michael Auerbach, MD, William E Strauss, MD, Iain C. Macdougall, MD, Kristine Bernard, MPH, Robert F Kaper, MD, Glenn M Chertow, MD MPH, Zhu Li, PhD, Anton Trochanov, MD, Naomi V Dahl, PharmD, Julie Krop, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3500.
https://doi.org/10.1182/blood.V130.Suppl_1.3500.3500
Published: 2017
Journal Articles

Efficacy and Safety of IV Ferumoxytol (FER) for Iron Deficiency Anemia (IDA) in Patients with Cancer

Saroj Vadhan-Raj, MD, Naomi V. Dahl, Pharm D, Kristine Bernard, MPH, Zhu Li, PhD, William Strauss, MD, F.A.C.C.
Journal: Blood
Blood (2014) 124 (21): 1352.
https://doi.org/10.1182/blood.V124.21.1352.1352
Published: 2014
Journal Articles

Safety and Efficacy Of Ferumoxytol For The Episodic Treatment Of Iron Deficiency Anemia In Patients With a History Of Unsatisfactory Oral Iron Therapy: Results Of a Phase III Open-Label, Six Month Extension Study

Saroj Vadhan-Raj, MD, Naomi V Dahl, Pharm.D., Gloria Lau, MSc, Kristine Bernard, Zhu Li, PhD, Pallabi De, PhD, Lee F. Allen, MD, PhD, William Strauss, M.D., F.A.C.C.
Journal: Blood
Blood (2013) 122 (21): 2201.
https://doi.org/10.1182/blood.V122.21.2201.2201
Published: 2013
Journal Articles

Ferumoxytol Treatment Results in Robust Hemoglobin Increases in Iron Deficiency Anemia Patients with a History of Unsatisfactory Oral Iron Therapy in a Phase III, Randomized, Placebo-Controlled Trial.

Saroj Vadhan Raj, Michael Cressman, David Ford, William Strauss, M.D., F.A.C.C., Gerri Poss, Kristine Bernard, Zhu Li, PhD, Lee F. Allen, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2098.
https://doi.org/10.1182/blood.V120.21.2098.2098
Published: 2012
Journal Articles

Potential New Treatment Option for Iron Deficiency Anemia Patients with a History of Unsatisfactory Oral Iron Therapy- Results of a Phase III, Randomized, Open-Label, Active-Controlled Trial of Ferumoxytol.

David Hetzel, Audrone Urboniene, Kristine Bernard, William Strauss, M.D., F.A.C.C., Michael Cressman, Zhu Li, PhD, Lee F. Allen, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2099.
https://doi.org/10.1182/blood.V120.21.2099.2099
Published: 2012
Journal Articles

Relationship Between Iron Indices and Iron Responsiveness Following IV Ferumoxytol or Oral Iron In Patients with CKD Not on Dialysis

John Adamson, MD, Zhu Li, PhD, Paul Miller, MS, Annamaria Kausz, MD, MS
Journal: Blood
Blood (2010) 116 (21): 5149.
https://doi.org/10.1182/blood.V116.21.5149.5149
Published: 2010